Top Markets
Coin of the day
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

CEMI
Ранг среди акций #33411
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in... Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
Цена акции
$0.455
Последняя синхронизация: 2023-04-27
Рыночная капитализация
$7.70M
Изменение (1 день)
0.22%
Изменение (1 год)
0.00%
Страна
US
Торговля Chembio Diagnostics, Inc. (CEMI)

Категория

EPS для Chembio Diagnostics, Inc. (CEMI)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Chembio Diagnostics, Inc., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Chembio Diagnostics, Inc. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US